[Pharmacological bases of therapy with 5-ASA]

Gastroenterol Hepatol. 1997 Jun-Jul;20(6):322-34.

[Article in Spanish]

Authors

B Beltrán¹, M A Martínez-Cuesta, S Calatayud, J Hinojosa, J V Esplugues

Affiliation

¹ Departamento de Farmacología, Facultad de Medicina y Odontología, Universidad de Valencia.

PMID: 9296850

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Aminosalicylic Acids / adverse effects
Aminosalicylic Acids / pharmacokinetics
Aminosalicylic Acids / pharmacology
Aminosalicylic Acids / therapeutic use*
Anti-Infective Agents / pharmacokinetics
Anti-Inflammatory Agents / adverse effects
Anti-Inflammatory Agents / pharmacokinetics
Anti-Inflammatory Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Colitis, Ulcerative / drug therapy
Crohn Disease / drug therapy
Delayed-Action Preparations
Female
Free Radicals
Humans
Male
Mesalamine
Sulfapyridine / pharmacokinetics
Sulfapyridine / therapeutic use
Sulfasalazine / adverse effects
Sulfasalazine / pharmacokinetics
Sulfasalazine / therapeutic use

Substances

Aminosalicylic Acids
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Delayed-Action Preparations
Free Radicals
Sulfasalazine
Mesalamine
Sulfapyridine